MetaCare Acquires Medical Distributor JK Medi...Expanding Hospital MRO Business View original image

MetaCare is strengthening its competitiveness in the hospital Management, Repair, and Operation (MRO) business by acquiring JK Medi, a distributor of medical consumables and medical equipment. The strategy is to secure a stable revenue base and expand its healthcare business portfolio by combining its existing medical distribution channels and hospital networks.


MetaCare, a KOSPI-listed company, announced on July 29 that it had signed a share purchase agreement with JK Medi. Established in 2021, JK Medi is a medical distribution company that supplies medical consumables and equipment to hospitals and medical institutions. Its major clients include group purchasing organizations, hospitals, and clinics, and it has also supplied related products to cosmetic surgery medical institutions.


In 2025, JK Medi recorded sales of approximately 3.79 billion won, operating profit of about 350 million won, and net profit of around 310 million won. This represents a sales increase of about 79% year-on-year, while operating profit grew significantly from about 13 million won to 350 million won, demonstrating both growth and profitability. The company has continued its growth trajectory this year as well.


Through this acquisition, MetaCare plans to integrate its existing medical distribution business with JK Medi’s client base and supply chain to build a comprehensive MRO portfolio encompassing medical consumables, aesthetic medical products, and medical equipment.


The strategy is to secure stable demand based on the existing hospital network, expand sales to external medical institutions, and increase cost competitiveness and supply stability through joint purchasing, standardization of items, and enhancement of inventory and logistics management.


A MetaCare representative stated, “JK Medi is a medical distribution company with rapid sales growth and stable profitability, and it is expected to create high synergy with MetaCare’s hospital network and existing distribution business. With this acquisition, we will simultaneously improve internal purchasing efficiency and expand external sales, thereby reinforcing the profit-generating hospital MRO business foundation.”


Last year, MetaCare posted consolidated sales of 32.8 billion won and operating profit of 1.3 billion won, while in the first quarter of this year, it achieved sales of 10.1 billion won and operating profit of 600 million won. Recently, MetaCare also became the largest shareholder of TechLabs, which reported 92.3 billion won in sales and 7.4 billion won in operating profit last year. With the acquisition of JK Medi, MetaCare is accelerating the expansion of its healthcare business portfolio, covering hospital management support, digital marketing, and medical distribution.



The acquisition of JK Medi is regarded as a strategic move for MetaCare to strengthen its medical distribution network and hospital MRO business, expanding overall competitiveness and profit base in the healthcare sector.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing